Biogen, Eisai get Japanese nod for Leqembi Intravenous Infusion for Alzheimer's Disease Ruchika Sharma25 Sep 2023 7:00 AM GMTTokyo: Eisai Co., Ltd. and Biogen Inc. have announced that humanized anti- soluble aggregated amyloid-beta (Aβ) monoclonal antibody LEQEMBI...
Health Bulletin 02/August/2023 Roshni Dhar2 Aug 2023 11:35 AM GMTHere are the top health stories for the day:Comparing Timeliness and Reliability of Medical Information: Google vs. ChatGPTAn interdisciplinary study...
Medical Bulletin 1/August/2023 Roshni Dhar1 Aug 2023 10:00 AM GMTHere are the top medical news of the day:Novel vaccine may hold key to prevent or reduce the impact of Alzheimer’s diseaseAlzheimer’s disease now...
Eli Lilly presents results from Phase 3 trial of Donanemab at Alzheimer's Association Conference Ruchika Sharma19 July 2023 7:09 AM GMTIndianapolis: Eli Lilly and Company has presented full results from the Phase 3 TRAILBLAZER-ALZ 2 study showing that donanemab significantly...
Medical Bulletin 18/July/2023 Isra Zaman18 July 2023 9:45 AM GMTHere are the top medical news for the day: Alzheimer's diagnosis new GuidelinesRecently, at the International Alzheimer's Congress (AAIC) in...
USFDA grants traditional approval for Eisai Leqembi for Alzheimer's disease treatment Ruchika Sharma7 July 2023 8:00 AM GMTStockholm:BioArctic AB's (publ)partner Eisai has announced that the U.S. Food and Drug Administration, FDA, has approved the supplemental Biologics...
Eisai seeks marketing nod for Lecanemab for early Alzheimer's disease treatment in South Korea Ruchika Sharma11 Jun 2023 7:15 AM GMTLecanemab is a humanized immunoglobulin gamma 1 (IgG1) monoclonal antibody directed against aggregated soluble (protofibril) and insoluble forms of...
USFDA advisory committee votes unanimously to confirm clinical benefit of Leqembi for Alzheimer's Disease Ruchika Sharma10 Jun 2023 8:00 AM GMTTokyo: Eisai Co., Ltd. and Biogen Inc. have announced that the U.S. Food and Drug Administration’s (FDA) Peripheral and Central Nervous System...
Eisai seeks marketing authorisation for Lecanemab to treat early Alzheimer's disease in Great Britain Ruchika Sharma23 May 2023 5:30 AM GMTLecanemab is a humanized immunoglobulin gamma 1 (IgG1) monoclonal antibody directed against aggregated soluble (protofibril) and insoluble forms of...
Menthol inhalation may improve cognitive function in Alzheimer's disease Roshni Dhar13 May 2023 5:55 AM GMTResearchers from Cima University of Navarra (Spain) have shown in animal models of Alzheimer's disease that inhaling menthol improves cognitive...
Health Bulletin 12/May/2023 Roshni Dhar12 May 2023 10:40 AM GMTHere are the top health stories for the day:RIP Dr Vandana Das: Medical fraternity shattered out on streets demanding Doctors Protection ActThe...
Roche collaborates with Eli Lilly to enhance early diagnosis of Alzheimer's disease Ruchika Sharma22 March 2023 9:30 AM GMTBasel: Roche has announced that it has entered into a collaboration with Eli Lilly and Company to support the development of Roche’s Elecsys Amyloid...
